APIPPRA Trial: Abatacept in at-risk rheumatoid arthritis patients Abatacept has been studied in seropositive clinically suspect arthralgia patients (at risk for rheumatoid arthritis) and shows the potential to delay or prevent the disease. https://t.co/w944yaXNOd https://t.co/UvTVRTK1er